| Embrace Wellness | |
|
1943 N Locust Grove Rd Meridian ID 83646 | |
| (208) 343-3883 | |
| Not Available |
| Full Name | Embrace Wellness |
|---|---|
| Speciality | Clinic/Center |
| Location | 1943 N Locust Grove Rd, Meridian, Idaho |
| Authorized Official Name and Position | Tammy L. Hadfield (PRESIDENT-OWNER) |
| Authorized Official Contact | 2082878400 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Embrace Wellness Po Box 819 Eagle ID 83616 Ph: (208) 343-3883 | Embrace Wellness 1943 N Locust Grove Rd Meridian ID 83646 Ph: (208) 343-3883 |
| NPI Number | 1083852982 |
|---|---|
| Provider Enumeration Date | 01/30/2009 |
| Last Update Date | 02/15/2024 |
| Medicare PECOS PAC ID | 2567529241 |
|---|---|
| Medicare Enrollment ID | O20090324000679 |
News Archive
Cipher Pharmaceuticals Inc. today announced that it has completed patient enrolment in its Phase III safety study of CIP-ISOTRETINOIN, the Company's novel, patented formulation of isotretinoin, which is used in the treatment of severe, nodular acne. The Phase III safety study is being conducted under a Special Protocol Assessment that was granted by the U.S. Food and Drug Administration (FDA).
Array BioPharma today announced an oncology agreement with Genentech, a member of the Roche Group, for the development of each company's small-molecule Checkpoint kinase 1 (ChK-1) program.
Physician scientists at the Texas Heart Institute at St. Luke's Episcopal Hospital (THI at St. Luke's) have been awarded a grant of almost $1.5 million by the National Institutes of Health for research into treatments for patients with end-stage heart failure that would combine heart-assist devices and adult stem-cell treatments.
Data collected in Japanese and Korean patients included in the global PALOMA3 trial provides evidence that combining palbociclib with fulvestrant is an effective strategy to overcome endocrine resistance in women with hormone receptor positive (HR+), HER2 negative (HER2-) advanced breast cancer.
The Obama administration on Friday rescinded most of a 2008 rule that granted sweeping protections to health care providers who opposed abortion, sterilization and other medical procedures on religious or moral grounds.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083852982 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261Q00000X | Clinic/center | N-32864 (Idaho) | Primary |
| Provider Name | Tammy L Hadfield |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1457456022 PECOS PAC ID: 9830162205 Enrollment ID: I20040813001031 |
News Archive
Cipher Pharmaceuticals Inc. today announced that it has completed patient enrolment in its Phase III safety study of CIP-ISOTRETINOIN, the Company's novel, patented formulation of isotretinoin, which is used in the treatment of severe, nodular acne. The Phase III safety study is being conducted under a Special Protocol Assessment that was granted by the U.S. Food and Drug Administration (FDA).
Array BioPharma today announced an oncology agreement with Genentech, a member of the Roche Group, for the development of each company's small-molecule Checkpoint kinase 1 (ChK-1) program.
Physician scientists at the Texas Heart Institute at St. Luke's Episcopal Hospital (THI at St. Luke's) have been awarded a grant of almost $1.5 million by the National Institutes of Health for research into treatments for patients with end-stage heart failure that would combine heart-assist devices and adult stem-cell treatments.
Data collected in Japanese and Korean patients included in the global PALOMA3 trial provides evidence that combining palbociclib with fulvestrant is an effective strategy to overcome endocrine resistance in women with hormone receptor positive (HR+), HER2 negative (HER2-) advanced breast cancer.
The Obama administration on Friday rescinded most of a 2008 rule that granted sweeping protections to health care providers who opposed abortion, sterilization and other medical procedures on religious or moral grounds.
› Verified 1 days ago
News Archive
Cipher Pharmaceuticals Inc. today announced that it has completed patient enrolment in its Phase III safety study of CIP-ISOTRETINOIN, the Company's novel, patented formulation of isotretinoin, which is used in the treatment of severe, nodular acne. The Phase III safety study is being conducted under a Special Protocol Assessment that was granted by the U.S. Food and Drug Administration (FDA).
Array BioPharma today announced an oncology agreement with Genentech, a member of the Roche Group, for the development of each company's small-molecule Checkpoint kinase 1 (ChK-1) program.
Physician scientists at the Texas Heart Institute at St. Luke's Episcopal Hospital (THI at St. Luke's) have been awarded a grant of almost $1.5 million by the National Institutes of Health for research into treatments for patients with end-stage heart failure that would combine heart-assist devices and adult stem-cell treatments.
Data collected in Japanese and Korean patients included in the global PALOMA3 trial provides evidence that combining palbociclib with fulvestrant is an effective strategy to overcome endocrine resistance in women with hormone receptor positive (HR+), HER2 negative (HER2-) advanced breast cancer.
The Obama administration on Friday rescinded most of a 2008 rule that granted sweeping protections to health care providers who opposed abortion, sterilization and other medical procedures on religious or moral grounds.
› Verified 1 days ago
Jared M Furgeson Dds Pllc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2700 W Cherry Ln, Suite 120, Meridian, ID 83642 Phone: 208-887-9000 | |
Hampton Roads Medical Specialists Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2131 S Bonito Way, Meridian, ID 83642 Phone: 208-489-9500 | |
Vast Durable Medical Equipment Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2985 S Meridian Rd Ste 140, Meridian, ID 83642 Phone: 208-860-2849 | |
Borron Family Medicine Pllc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 790 W Ustick Rd, Ste 110, Meridian, ID 83646 Phone: 208-639-3990 Fax: 208-639-3992 | |
Primary Health Medical Group Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1623 South Wells Avenue, Meridian, ID 83642 Phone: 208-489-1450 Fax: 208-489-1451 | |
Virtare Health Physician Services Of Idaho, Pllc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3597 E Monarch Sky Ln Ste 240, Meridian, ID 83646 Phone: 855-745-8400 | |
Terry Reilly Health Services Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3115 E Florence Dr, Meridian, ID 83642 Phone: 208-932-8992 Fax: 208-370-6215 |